What is the trial? Sponsor is developing the product RYI-018 as a potential treatment for non-alcoholic fatty liver disease (NAFLD), which is a very common disorder and refers to a …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Adults and Children ages 9+ may qualify for a study of an investigational facial acne medication. To participate you must: Have at least 20 red irritated pimples and at least …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 9 and above
TRIAL STATUS: Completed
Help us trial a medication which may help to protect people against severe reactions to peanuts. We’re looking for healthy people aged 18-65 with with a documented peanut allergy (of …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Australian researchers are trialing a potential new treatment for Asthma. They are looking for volunteers to take part in the Australian arm of a worldwide study. This study will be …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 18 to 100 years
TRIAL STATUS: Completed
Are you aged between 50 and 80? Do you have Diabetes? You could play a role in the prevention of heart disease by participating in the ViKCoVaC study. Led by …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 50 to 80 years
TRIAL STATUS: Recruiting
This is a phase 2, open-label trial designed to evaluate the safety, tolerability, biologic activity, and preliminary efficacy of intratumoral SD 101 injections in combination with Keytruda (pembrolizumab) in patients …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Linear is currently inviting volunteers who have impaired function of their pancreas (a condition called exocrine pancreatic insufficiency, or EPI). This condition is often caused by chronic pancreatitis, or where part …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
The study is conducted in response to the need to maintain older adults’ daily functioning through stimulating environments despite the aging process. This study will involve older adults playing video games …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 40 and above
TRIAL STATUS: Recruiting
The purpose of this study is to collect data. The sponsor will be collecting medical information from study participants (through an interview and a phone call up to 7 days …
CONDITION: Blood
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Terminated
20150164: This study is investigating a drug that has been developed for the treatment of a disease called Paroxysmal nocturnal hemoglobinuria (PNH) – PNH is a disease where red blood …
CONDITION: Other
GENDER: Males
AGE GROUP: 18 to 45 years
TRIAL STATUS: Completed
Are you in Good Health? Are you aged 18 or over? Do you live in Sydney? You may qualify* to take part in a trial looking at the potential changes …
CONDITION: Oral and Gastrointestinal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
What is COMPARE? COMPARE is an Australian national randomised controlled trial which aims to compare two types of intensive speech pathology treatments (Constraint Induced Aphasia Therapy; Multi-modality Aphasia Therapy) to …
CONDITION: Stroke
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
This is a phase I study assessing the safety and tolerability of single dose of a study drug which is being developed for the treatment of hyperuricemia and gout. Eligible …
CONDITION: Other
GENDER: Males
AGE GROUP: 18 to 50 years
TRIAL STATUS: Closed: follow-up complete
This is an open label, phase I study assessing the safety and tolerability of a pharmaceutical formulation comprising a protein that is being developed as a treatment for acute ischemic stroke. …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 to 50 years
TRIAL STATUS: Closed: follow-up continuing
This study for patients with Stage III non-small cell lung cancer seeks to assess whether the addition of oral veliparib versus placebo to Paclitaxel/Carboplatin-based chemoradiotherapy with Paclitaxel/Carboplatin consolidation will improve …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Terminated
The purpose of this project is to investigate the effectiveness and safety of early antivenom administration for the treatment of red-bellied black snake bites/envenoming. Red-bellied black snakebites (RBBS) are the …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Do you have a painful and stiff knee? Does it affect your ability to talk long distances, to walk up flights of stairs? Is Your knee pain affecting your sleep …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 21 to 75 years
TRIAL STATUS: Recruiting
Snake bites are not common in Australia, but cause severe effects and often occur in rural and regional parts of Australia. Antivenoms exist for the treatment of many of these …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
A Phase 1, Single-Center, Open-label Study to Evaluate the Safety and Pharmacokinetics of Two Tablet Formulations of PRN1008. The purpose of this study is to investigate the relative bioavailability (the …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Closed: follow-up complete
Have you been diagnosed with or suspected to have a nodular Basal Cell Carcinoma (BCC)? CLINICAL RESEARCH STUDY We are seeking volunteers with nodular BCC to participate in a …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
This research project is testing the safety, tolerability and efficacy (the effect of the drug on the body) of AKP-11 administered to participants with atopic dermatitis. You are invited to …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
Genital Psoriasis If you have psoriasis with genital involvement, you’re not alone. Up to two thirds of people with psoriasis report genital involvement at some point during their lives. That’s …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
AKP-11 is being developed as a treatment for psoriasis. AKP-11 has been tested on a small population of psoriasis subjects previously, which showed a reduction in psoriasis severity. By participating …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
Are you aged 40 years or over? Do you suffer from COPD? Are you a current or previous smoker? Using Seretide? If you answered yes to these questions, you may be …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 40 and above
TRIAL STATUS: Completed
people suffering with Acute Pain 1 visit of approximately 2 hours assessing a survey for people affected by Acute Pain in Australia If you suffer from Acute Pain or know someone who does, contact us for …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
people suffering with Chronic Pain 1 visit of approximately 2 hours assessing a survey for people affected by Chronic Pain in Australia If you suffer from Chronic Pain or know someone who does, …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
If you answered yes to these questions, you may be able to take part in a new research study. Our Research Centre in Drummoyne is participating in the study. …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting